CDT Equity Inc. (CDT) vs Lunai Bioworks Inc. (LNAI)

CDT Equity Inc. and Lunai Bioworks Inc. are both Biotechnology companies. Lunai Bioworks Inc. is the larger, with a market value of $830.0K against $390.0K — 2.1× the size. CDT Equity Inc. has the higher net margin (0.00% vs −3,761.9%) and the lower return on invested capital (−21.3% vs 0.00%). Across the 11 metrics below, Lunai Bioworks Inc. leads on 6 and CDT Equity Inc. on 5.

Valuation

Metric CDT LNAI Biotechnology median
P/E n/m n/m 10.60
P/S n/m 5.68 9.40
P/B 0.00 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 0.25 9.02
Earnings yield (10,527,125.00%) (640.81%) (32.88%)
Free cash flow yield (43,606.95%) (988.00%) (23.13%)

Profitability

Metric CDT LNAI Biotechnology median
Gross margin — (3.48%) 68.51%
Operating margin 0.00% (9,184.79%) 0.00%
Net margin 0.00% (3,761.88%) 0.00%
Free cash flow margin 0.00% (5,610.24%) 0.00%
Return on equity (69.68%) 23.46% (51.96%)
Return on assets (55.16%) (39.21%) (46.06%)
Return on invested capital (21.28%) 0.00% 0.00%

Growth

Metric CDT LNAI Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 98.09% 98.77% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CDT LNAI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.13 0.11 4.97
Net debt to EBITDA 0.05 0.20 1.01

Dividend

Metric CDT LNAI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CDT LNAI Biotechnology median
Market cap 390.00k 830.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack